Literature DB >> 12672315

LIR-1 expression on lymphocytes, and cytomegalovirus disease in lung-transplant recipients.

Louise Berg1, Gerdt C Riise, David Cosman, Tomas Bergström, Sigvard Olofsson, Klas Kärre, Ennio Carbone.   

Abstract

Human cytomegalovirus infection is a major cause of morbidity after lung transplantation. LIR-1 (leucocyte immunoglobulin-like receptor-1) is an inhibitory cell surface receptor that has high affinity for an MHC class I homologue (UL18) encoded by human cytomegalovirus. We aimed to investigate whether reactivation of human cytomegalovirus affects the expression of LIR-1. We measured LIR-1 expression on peripheral blood lymphocytes from 13 lung-transplant recipients and established human cytomegalovirus load using PCR. Eight patients developed cytomegalovirus disease. The percentage of cells expressing LIR-1 increased in the patients who developed cytomegalovirus disease several weeks before viral DNA was detectable by PCR. Measurement of LIR-1 expression might allow early identification of cytomegalovirus disease in lung-transplant patients.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12672315     DOI: 10.1016/S0140-6736(03)12855-3

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  18 in total

Review 1.  Functional and genetic diversity of leukocyte immunoglobulin-like receptor and implication for disease associations.

Authors:  Kouyuki Hirayasu; Hisashi Arase
Journal:  J Hum Genet       Date:  2015-06-04       Impact factor: 3.172

2.  Partial break in tolerance of NKG2A-/LIR-1- single KIR+ NK cells early in the course of HLA-matched, KIR-mismatched hematopoietic cell transplantation.

Authors:  S Rathmann; C Keck; C Kreutz; N Weit; M Müller; J Timmer; S Glatzel; M Follo; M Malkovsky; M Werner; R Handgretinger; J Finke; P Fisch
Journal:  Bone Marrow Transplant       Date:  2017-05-08       Impact factor: 5.483

Review 3.  Leukocyte immunoglobulin-like receptors in human diseases: an overview of their distribution, function, and potential application for immunotherapies.

Authors:  Jilu Zhang; Sunny Mai; Hui-Ming Chen; Kyeongah Kang; Xian Chang Li; Shu-Hsia Chen; Ping-Ying Pan
Journal:  J Leukoc Biol       Date:  2017-03-28       Impact factor: 4.962

4.  Increased expression of the natural killer cell inhibitory receptor CD85j/ILT2 on antigen-specific effector CD8 T cells and its impact on CD8 T-cell function.

Authors:  M Nedim Ince; Brooke Harnisch; Zhan Xu; Sang-Kyung Lee; Christoph Lange; Lorenzo Moretta; Michael Lederman; Judy Lieberman
Journal:  Immunology       Date:  2004-08       Impact factor: 7.397

Review 5.  Regulation of T-cell immunity by leucocyte immunoglobulin-like receptors: innate immune receptors for self on antigen-presenting cells.

Authors:  Katie J Anderson; Rachel L Allen
Journal:  Immunology       Date:  2009-05       Impact factor: 7.397

6.  Genetic variability of the major histocompatibility complex class I homologue encoded by human cytomegalovirus leads to differential binding to the inhibitory receptor ILT2.

Authors:  Mar Valés-Gómez; Mitsunori Shiroishi; Katsumi Maenaka; Hugh T Reyburn
Journal:  J Virol       Date:  2005-02       Impact factor: 5.103

7.  LILRB1 polymorphisms influence posttransplant HCMV susceptibility and ligand interactions.

Authors:  Kang Yu; Chelsea L Davidson; Agnieszka Wójtowicz; Luiz Lisboa; Ting Wang; Adriana M Airo; Jean Villard; Jeremie Buratto; Tatyana Sandalova; Adnane Achour; Atul Humar; Katia Boggian; Alexia Cusini; Christian van Delden; Adrian Egli; Oriol Manuel; Nicolas Mueller; Pierre-Yves Bochud; Deborah N Burshtyn
Journal:  J Clin Invest       Date:  2018-03-12       Impact factor: 14.808

8.  The human cytomegalovirus MHC class I homolog UL18 inhibits LIR-1+ but activates LIR-1- NK cells.

Authors:  Virginie Prod'homme; Cora Griffin; Rebecca J Aicheler; Eddie C Y Wang; Brian P McSharry; Carole R Rickards; Richard J Stanton; Leszek K Borysiewicz; Miguel López-Botet; Gavin W G Wilkinson; Peter Tomasec
Journal:  J Immunol       Date:  2007-04-01       Impact factor: 5.422

9.  Characterization of a highly glycosylated form of the human cytomegalovirus HLA class I homologue gpUL18.

Authors:  Cora Griffin; Eddie C Y Wang; Brian P McSharry; Carole Rickards; Helena Browne; Gavin W G Wilkinson; Peter Tomasec
Journal:  J Gen Virol       Date:  2005-11       Impact factor: 3.891

10.  Impact of the NK cell receptor LIR-1 (ILT-2/CD85j/LILRB1) on cytotoxicity against multiple myeloma.

Authors:  Silke Heidenreich; Christine Zu Eulenburg; York Hildebrandt; Thomas Stübig; Heidi Sierich; Anita Badbaran; Thomas H Eiermann; Thomas M C Binder; Nicolaus Kröger
Journal:  Clin Dev Immunol       Date:  2012-07-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.